MarketPulse

pharmaceutical innovation

11 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Peptide Drug Conjugates Poised for $1.5B Market by 2031 as Oncology Focus Accelerates

Peptide drug conjugate market projected to reach $1.5 billion by 2031 with 14%+ CAGR, driven by targeted oncology therapies and innovative linker technologies from major biotech players.
NVSBCYCPEPGclinical trialspharmaceutical innovation
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Bile Duct Cancer Market Eyes $3.89B by 2030 on Therapy Advances

Global bile duct cancer market projected to reach $3.89B by 2030 from $2.59B in 2025, driven by immunotherapy, AI diagnostics, and rising disease prevalence.
BMYCELGrABBVLLYAZN+1pharmaceutical innovationimmunotherapy
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Esophageal Cancer Market Set to Surge 44% by 2030 as Big Pharma Races for Share

Esophageal cancer market projected to grow 44% to $2.37B by 2030 at 9.5% CAGR, with Pfizer, Roche, and Merck dominating through precision oncology and immunotherapy innovations.
BMYCELGrMRKPFENVS+2pharmaceutical innovationmarket growth
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Regeneron Stock Rally Masks Reality: Respectable Returns, Not Millionaire-Maker Gains

Regeneron's 35% recovery masks limited multimillionaire potential at $79B valuation, positioning shares for S&P-matching returns rather than exceptional gains.
REGNbiotechclinical trials
BenzingaBenzinga··Vandana Singh

Roche Deploys 2,176 NVIDIA GPUs in Landmark AI Factory for Drug Discovery

Roche and NVIDIA expand AI infrastructure with 2,176 on-premises GPUs across U.S. and Europe, totaling 3,500 Blackwell units to accelerate drug discovery and diagnostics.
NVDARHHBYAI infrastructurepharmaceutical innovation
BenzingaBenzinga··Lekha Gupta

NASA Awards Redwire $4M for Drug Development, Bolstering Space-Based Research Platform

NASA awards Redwire $4 million for drug development in cancer, osteoporosis, and obesity. Shares rise 0.98% following funding announcement.
RDWspace technologypharmaceutical innovation
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Global Antibiotics Market Poised for Steady Growth as Innovation Tackles Resistance Crisis

Global antibiotics market to grow from USD 55.60B in 2025 to USD 70.64B by 2031 at 4.07% CAGR, driven by antimicrobial resistance and innovation.
JNJMRKPFELLYSNY+4Asia Pacific growthpharmaceutical innovation
GlobeNewswire Inc.GlobeNewswire Inc.··Dndi And Sanofi

DNDi-Sanofi sleeping sickness drug wins EMA backing as simplified single-dose option

EMA approves DNDi-Sanofi's Acoziborole Winthrop, a simplified single-dose sleeping sickness treatment with 96% efficacy. Sanofi will donate it to WHO for endemic countries.
SNYsleeping sicknessCHMP approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Eton Pharma Gains FDA Clearance for First Liquid Desmopressin Formulation

Eton Pharma gains FDA approval for DESMODA, the first liquid desmopressin formulation for central diabetes insipidus, launching March 9 with projected peak sales of $30-50 million.
ETONFDA approvalrare disease
Investing.comInvesting.com··Jeffrey Neal Johnson

Healthcare Giant Johnson & Johnson Outpaces Tech Sector on Dividend Strength

J&J stock hits record highs with 14% monthly returns, outperforming tech due to stable dividends, strong cash flow, and lower volatility amid market uncertainty.
JNJdividend growthpharmaceutical innovation
The Motley FoolThe Motley Fool··Adria Cimino

Vertex Pharmaceuticals Diversifies Beyond Cystic Fibrosis With Gene-Editing Expansion

Vertex Pharmaceuticals expands beyond cystic fibrosis dominance into gene-editing treatments for blood disorders and pain management, targeting $13.1B revenue with non-CF products generating $500M+.
VRTXbiotechpharmaceutical innovation